US Stock MarketDetailed Quotes

TNGX Tango Therapeutics

Watchlist
  • 7.770
  • +0.460+6.29%
Close Apr 23 16:00 ET
829.20MMarket Cap-7194P/E (TTM)

About Tango Therapeutics Company

Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin, Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.

Company Profile

SymbolTNGX
Company NameTango Therapeutics
Listing DateSep 3, 2020
Issue Price10.00
Founded2017
CEODr. Barbara L. Weber, M.D.
MarketNASDAQ
Employees140
Securities TypeOrdinary Shares
Fiscal Year Ends12-31
Address201 Brookline Avenue,Suite 901
CityBoston
ProvinceMassachusetts
CountryUnited States of America
Zip Code02215
Phone1-857-320-4900
Websitehttp://www.tangotx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Barbara L. Weber, M.D.
  • President, Chief Executive Officer and Director
  • 4.68M
  • Douglas Barry
  • General Counsel, Chief Compliance Officer and Corporate Secretary
  • --
  • Daniella Beckman
  • Chief Financial Officer
  • 1.52M
  • Dr. Jannik Andersen, PhD
  • Chief Scientific Officer
  • --
  • Alexis A. Borisy, A.M.
  • Chairman of the Board
  • 239.28K
  • Dr. Adam Crystal, M.D.,PhD
  • President, Research & Development
  • --
  • Kanishka Pothula
  • Director
  • --
  • Dr. Mace Rothenberg, M.D.
  • Independent Director
  • 209.28K
  • Lesley Ann Calhoun
  • Independent Director
  • 215.78K
  • John B. Ketchum
  • Independent Director
  • --
  • Dr. Malte Peters, M.D.
  • Independent Director
  • 206.78K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg